BG28055A3 - Метод за получаване на фенилпиперазинови производни - Google Patents

Метод за получаване на фенилпиперазинови производни

Info

Publication number
BG28055A3
BG28055A3 BG037191A BG3719177A BG28055A3 BG 28055 A3 BG28055 A3 BG 28055A3 BG 037191 A BG037191 A BG 037191A BG 3719177 A BG3719177 A BG 3719177A BG 28055 A3 BG28055 A3 BG 28055A3
Authority
BG
Bulgaria
Prior art keywords
obtaining
phenylpiperazine derivatives
phenylpiperazine
derivatives
proven
Prior art date
Application number
BG037191A
Other languages
Bulgarian (bg)
English (en)
Inventor
John Verge
William Jamieson
Original Assignee
Lilly Industries Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Limited filed Critical Lilly Industries Limited
Publication of BG28055A3 publication Critical patent/BG28055A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BG037191A 1976-04-23 1977-04-20 Метод за получаване на фенилпиперазинови производни BG28055A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16526/76A GB1575904A (en) 1976-04-23 1976-04-23 Phenyl piperazines

Publications (1)

Publication Number Publication Date
BG28055A3 true BG28055A3 (bg) 1980-02-25

Family

ID=10078930

Family Applications (2)

Application Number Title Priority Date Filing Date
BG037191A BG28055A3 (bg) 1976-04-23 1977-04-20 Метод за получаване на фенилпиперазинови производни
BG036062A BG27746A3 (bg) 1976-04-23 1977-04-20 Метод за получаване на фенилпиперазинови производни

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG036062A BG27746A3 (bg) 1976-04-23 1977-04-20 Метод за получаване на фенилпиперазинови производни

Country Status (34)

Country Link
JP (1) JPS52151183A (de)
AR (2) AR222003A1 (de)
AT (1) AT355579B (de)
AU (1) AU514822B2 (de)
BE (1) BE853899A (de)
BG (2) BG28055A3 (de)
CA (1) CA1087617A (de)
CH (2) CH633009A5 (de)
CS (1) CS196360B2 (de)
DD (1) DD129790A5 (de)
DE (1) DE2717415A1 (de)
DK (1) DK176177A (de)
ES (2) ES457988A1 (de)
FI (1) FI63937C (de)
FR (1) FR2348925A1 (de)
GB (1) GB1575904A (de)
GR (1) GR64084B (de)
HU (1) HU176820B (de)
IE (1) IE44730B1 (de)
IL (1) IL51787A (de)
LU (1) LU77170A1 (de)
MX (1) MX4596E (de)
NL (1) NL7704456A (de)
NO (1) NO146710C (de)
NZ (1) NZ183715A (de)
OA (1) OA05643A (de)
PH (1) PH14124A (de)
PL (1) PL117466B1 (de)
PT (1) PT66452B (de)
RO (1) RO72831A (de)
SE (1) SE7704536L (de)
SU (2) SU664564A3 (de)
YU (1) YU104477A (de)
ZA (1) ZA771849B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601310A (en) * 1978-05-23 1981-10-28 Lilly Industries Ltd Aryl hydantoins
DE3142608A1 (de) * 1981-10-28 1983-05-05 Basf Ag, 6700 Ludwigshafen Polyazofarbstoffe
JPH07157477A (ja) * 1993-12-02 1995-06-20 Asahi Kagaku Kogyo Kk チアゾール誘導体の製造方法
MX9603998A (es) * 1994-03-11 1997-12-31 Yamanouchi Pharma Co Ltd Agonista receptor de 5-ht3, derivado de tiazol novedoso e intermediario del mismo.
CA2144669A1 (en) * 1994-03-29 1995-09-30 Kozo Akasaka Biphenyl derivatives
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
DZ3292A1 (fr) * 2001-09-13 2005-05-14 Solvay Pharm Gmbh Nouveaux composes de type 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]piperazine, methodes pour les preparer et medicaments renfermant cescomposes
BRPI0708337A2 (pt) 2006-02-28 2011-05-24 Helicon Therapeutics Inc pipirazinas terapêutica como inibidores pde4
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines

Also Published As

Publication number Publication date
FI63937B (fi) 1983-05-31
DD129790A5 (de) 1978-02-08
NO146710C (no) 1982-11-24
PL117466B1 (en) 1981-08-31
IL51787A (en) 1980-02-29
HU176820B (en) 1981-05-28
IL51787A0 (en) 1977-05-31
AT355579B (de) 1980-03-10
GB1575904A (en) 1980-10-01
BG27746A3 (bg) 1979-12-12
LU77170A1 (de) 1979-01-18
ES457988A1 (es) 1978-07-16
ZA771849B (en) 1978-11-29
JPS52151183A (en) 1977-12-15
DE2717415A1 (de) 1977-11-10
NL7704456A (nl) 1977-10-25
IE44730L (en) 1977-10-23
CH625802A5 (en) 1981-10-15
ATA285177A (de) 1979-08-15
NO146710B (no) 1982-08-16
GR64084B (en) 1980-01-21
AU2438677A (en) 1978-10-26
OA05643A (fr) 1981-04-30
IE44730B1 (en) 1982-03-10
PH14124A (en) 1981-02-26
DK176177A (da) 1977-10-24
NZ183715A (en) 1980-04-28
BE853899A (fr) 1977-10-24
SU664564A3 (ru) 1979-05-25
PT66452B (en) 1979-03-09
SE7704536L (sv) 1977-10-24
CA1087617A (en) 1980-10-14
RO72831B (ro) 1983-07-30
FR2348925B1 (de) 1980-04-11
AU514822B2 (en) 1981-02-26
NO771398L (no) 1977-10-25
FI771287A7 (de) 1977-10-24
MX4596E (es) 1982-06-25
FR2348925A1 (fr) 1977-11-18
CS196360B2 (en) 1980-03-31
YU104477A (en) 1983-01-21
PL197550A1 (pl) 1979-05-21
RO72831A (ro) 1983-08-03
ES467948A1 (es) 1978-11-01
CH633009A5 (en) 1982-11-15
SU727146A3 (ru) 1980-04-05
PT66452A (en) 1977-05-01
AR222635A1 (es) 1981-06-15
AR222003A1 (es) 1981-04-15
FI63937C (fi) 1983-09-12

Similar Documents

Publication Publication Date Title
BG28052A4 (bg) Метод за получаване на аминоалкилхетероцикли
BG39467A3 (bg) Метод за получаване на карбоксиалкилни дипептиди
BG31499A3 (bg) Метод за получаване на 1-винилтриазолови производни
BG28061A3 (en) Method of obtaining of hexahydrodibenzopyranones
BG36044A3 (bg) Метод за получаване на пиперазинови производни
BG28847A3 (bg) Метод за получаване на хидантоинови производни
BG32850A3 (en) Method for obtaining of 6 a, 10 a- cis- hexahydrodibenzopyranols
BG29722A3 (bg) Метод за получаване на 2,5-дисубституирани пиримидин-4-они
BG31377A3 (bg) Метод за получаване на фенилетиламини
BG28068A3 (bg) Метод за получаване на -3- хлорцефалоспорини
BG34185A3 (bg) Метод за получаване на пиперазинилпиразиново производно
BG28849A3 (bg) Метод за получаване на гамапирони
BG28071A3 (bg) Метод за получаване на 2-деоксистрептаминаминогликозиди
BG28573A3 (bg) Метод за получаване на аминоалкоксифенилови производни
BG30778A3 (en) Method for obtaining of eburnamenine derivatives
BG35746A3 (bg) Метод за получаване на 1-циклохексенилметил прдукти
BG35464A3 (en) Method preparing fluorene derivatives
BG28064A3 (en) Method of obtaining of 2,6-methane-2h-1-benzoxozines
BG31073A3 (bg) Метод за получаване на 1,5-заместени-2-пиролидони
BG33292A3 (bg) Метод за получаване на пенамсулфоокисни производни
BG28054A3 (bg) Метод за получаване на 2-(4-ароил-пиперазин-1-ил)-4-амино-6,7- диметоксихиназолини
BG30475A3 (bg) Метод за получаване на депостероидни естери
BG28845A3 (bg) Метод за получаване на n-алкилдифениламини
BG28416A4 (en) Method of obtaining of benzo (c) hinolines
BG33295A3 (bg) Метод за получаване на виндезин